You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Vasculitis

Upadacitinib for treating giant cell arteritis [ID6299]

  • In development
  • Reference number: GID-TA11330
  • Expected publication date:  21 May 2026
  • Project information
  • Project documents
  • Consultation

On this page

  1. Draft guidance
  2. Declaration of interests
  3. Invitation to participate
  4. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6299

Documents

Documents created during the development process.

Draft guidance

  • Draft guidance

  • Draft guidance (downloadable version) (PDF 242 KB)

    Published:
    14 January 2026
  • Draft guidance (online commenting)

  • Committee papers (PDF 10.96 MB)

    Published:
    14 January 2026
  • Public committee slides (PDF 1.22 MB)

    Published:
    14 January 2026
  • Equality impact assessment (downloadable version) (PDF 129 KB)

    Published:
    14 January 2026

Declaration of interests

  • Register of interests (PDF 151 KB)

    Published:
    14 January 2026

Invitation to participate

  • Final scope (PDF 91 KB)

    Published:
    17 March 2025
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 352 KB)

    Published:
    17 March 2025
  • Equality impact assessment (scoping) (PDF 51 KB)

    Published:
    17 March 2025
  • Final stakeholder list (PDF 93 KB)

    Published:
    23 May 2025

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6299

  • Draft scope post referral (PDF 166 KB)

    Published:
    23 January 2025
  • Draft matrix post referral (PDF 164 KB)

    Published:
    23 January 2025
Back to top